PEPCID antacid tablets recalled for improper storage temperature handling
Family Dollar Stores is recalling three PEPCID antacid products due to improper storage temperature conditions at specific Family Dollar locations from April through June 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves improper storage conditions at the manufacturing stage. No illnesses or injuries have been reported, and the hazard is theoretical rather than confirmed. Voluntary precautionary recalls without reported harm are classified as Moderate.
Plain-English summary
Family Dollar Stores, LLC is recalling PEPCID antacid tablet products distributed to select Family Dollar store locations from April 30, 2022 through June 10, 2022. The products were stored outside of appropriate temperature conditions, which constitutes a Current Good Manufacturing Practice (CGMP) deviation.
The recalled products include: PEPCID COMPLETE CHEWABLE TABLETS BERRY (8 count, SKU 903365), PEPCID AC MAXIMUM STRENGTH TABLETS (25 count, SKU 902063), and PEPCID AC MAXIMUM STRENGTH TABLETS (8 count, SKU 914773).
Consumers who have purchased these products should stop using them and return them to the retailer for a refund.
No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- PEPCID COMPLETE CHEWABLE TAB BERRY 8CT SKU 903365 PEPCID AC MAXIMUM STRENGTH TABLET 25 CT SKU 902063 PEPCID AC MAXIMUM STRENGTH TABLET 8 CT SKU 914773 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Antacid
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs: 903365
- 902063
- 914773
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27